• FDA Approves Fasenra for Severe Asthma Stemming from Immune Cell Glut
  • Veracyte’s Genomic Tool Aids in Diagnosing IPF Without Surgery, Real-world Data Suggests
  • Ofev Slows Scarring in Pulmonary Fibrosis Patients’ Lungs, Phase 3b Trial Shows
  • Canadian Association Conducting Purple Challenge Campaign During PH Awareness Month
  • ATS Foundation, Boehringer Ingelheim Fund New Fellowship on IPF Research
  • Esbriet Safe but Less Effective in Severe IPF Patients After 6 Months of Treatment, Small Study Says
  • Esbriet Treatment Helps Reduce Cough in IPF Patients, European Study Shows
  • FDA Approves Genentech’s Alecensa as First-line Therapy for ALK-positive, Advanced NSCLC
  • Cancer Factor Has Potential as Lung Fibrosis Treatment Target, Chinese Study Finds
  • Dogs May Help Protect Children Against Asthma and Eczema, Studies Shows
  • Real-World Study Confirms Benefits of Percepta Genomic Classifier in Diagnosing Lung Cancer
  • Experts Release New Guidelines for Lung Cancer Screening at CHEST 2017

Pulmonary Fibrosis

Asthma

Bronchiectasis

BRONCHIOLITIS

CHRONIC BRONCHITIS

COPD

 CYSTIC FIBROSIS

EMPHYSEMA

IDIOPATHIC PULMONARY FIBROSIS

LUNG CANCER

PNEUMONIA

PULMONARY HYPERTENSION

SCLERODERMA